Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carlyle Group LP

40.50
-0.2600-0.64%
Post-market: 40.28-0.2200-0.54%16:21 EDT
Volume:2.11M
Turnover:86.30M
Market Cap:14.62B
PE:14.62
High:41.54
Open:40.24
Low:40.08
Close:40.76
Loading ...

Carlyle's NSM Insurance to Sell U.S. Commercial Insurance Business to New Mountain

MT Newswires Live
·
24 Feb

Nsm Insurance Group - Aaron Miller to Become CEO of New Entity Backed by New Mountain

THOMSON REUTERS
·
24 Feb

Nsm Insurance Group Announces Definitive Agreement for New Mountain Capital to Acquire Its U.S. Commercial Insurance Division

THOMSON REUTERS
·
24 Feb

Press Release: NSM Insurance Group Announces Definitive Agreement for New Mountain Capital to Acquire Its U.S. Commercial Insurance Division

Dow Jones
·
24 Feb

Why CG Oncology, Inc. (CGON) is the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey
·
24 Feb

Top Midday Decliners

MT Newswires Live
·
22 Feb

Top Midday Stories: UnitedHealth Under DOJ Investigation Over Medicare Billing Practices; Novo Nordisk Resolves Ozempic Shortage

MT Newswires Live
·
22 Feb

Carlyle price target lowered to $47 from $50 at BofA

TipRanks
·
21 Feb

BRIEF-Bluebird Bio Announces Definitive Agreement To Be Acquired By Carlyle And SK Capital

Reuters
·
21 Feb

What's Going On With Gene Therapy Company Bluebird Bio Stock Today?

Benzinga
·
21 Feb

BUZZ-Bluebird bio falls on discounted take private deal with Carlyle, SK Capital

Reuters
·
21 Feb

Bluebird bio to Be Acquired by Carlyle Group, SK Capital

Dow Jones
·
21 Feb

Gene therapy maker bluebird to go private in discounted deal amid cash crunch

Reuters
·
21 Feb

bluebird bio Agrees to be Acquired by Carlyle Group, SK Capital Partners; Trading Halted Pre-Bell

MT Newswires Live
·
21 Feb

Bluebird bio agrees to be acquired by Carlyle and SK Capital

Reuters
·
21 Feb

bluebird bio: Entered Into Amendments to Loan Agreement With Hercules Capital to Facilitate Adequate Liquidity

THOMSON REUTERS
·
21 Feb

bluebird bio Announces Definitive Agreement to Be Acquired by Carlyle and SK Capital

THOMSON REUTERS
·
21 Feb

bluebird bio Inc - Stockholders to Receive $3.00 per Share in Cash

THOMSON REUTERS
·
21 Feb

bluebird bio Inc - David Meek Expected to Become CEO of Bluebird Upon Closing of Deal

THOMSON REUTERS
·
21 Feb

bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital

Business Wire
·
21 Feb